Follow-up Care After Treatment for Endometrial Cancer

Endometrial Neoplasm Clinical Trial

Official title:

Follow-up After Primary Therapy for Endometrial Cancer; Implementation of a Cancer Care Ontario Guideline: A Pilot Evaluation Study.

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00750672
• Other study ID #: OHRI 2008-361
• Secondary ID: 2008361-01H for
• Status: Completed
• Phase: N/A
• First received: September 9, 2008
• Last updated: July 11, 2012
• Start date: August 2008
• Est. completion date: February 2010

Study information

• Verified date: July 2012
• Source: Ottawa Hospital Research Institute
• Contact: n/a
• Is FDA regulated: No
• Health authority: Canada: Ethics Review Committee
• Study type: Observational

Clinical Trial Summary

The purposes of this study are to examine the needs (symptoms, support, information) and satisfaction of women during follow-up in the community after completing treatment for endometrial cancer. This information will be collected from the perspective of the women themselves, their primary care providers (family physician or gynecologist) and the health care providers (oncologist, nurses, social worker, psychologist) at the cancer centre.

Description:

Research Question How has this transfer in follow-up care impacted performance indicators?

• Volume of follow-up care transferred

• Percentage of women, who have required a re-entry consultation

• Fiscal implication of this transfer of follow-up care

Patient stakeholders:

• What are women's perceptions of the transition of follow-up care?

• What are women's supportive care needs during the transition of follow-up care and ongoing needs?

Primary Care Practitioner stakeholders:

• What are the primary care practitioners' perceptions of the process of transition of follow-up care?

• What are the primary care practitioners' educational needs?

• What are the primary care practitioners' perceptions of the process of re-entry for in women with suspected recurrence?

Tertiary Centre: Health care providers stakeholders

o What are the perceptions of tertiary health care providers about the transition of follow-up care?

Recruitment information / eligibility

• Status: Completed
• Enrollment: 20
• Est. completion date: February 2010
• Est. primary completion date: September 2009
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Participants- women diagnosed with endometrial cancer:

• 18 years of age or older.

• speak English or French

• who have been treated (surgery and/or radiation therapy) at TOH.

• who have been discharged from follow-up in the cancer centre in the past 6 months.

• Participants-primary care provider practitioner:

• providing follow-up care to at least one woman with endometrial cancer

• Participants- health care providers at the tertiary centre :

• physicians, nurses or allied health care providers whose primary responsibility are to provide care to women with gynecological cancer.

Exclusion Criteria:

Study Design

Observational Model: Ecologic or Community, Time Perspective: Retrospective

Related Conditions & MeSH terms

• Endometrial Neoplasm
• Endometrial Neoplasms

Locations

Country	Name	City	State
Canada	The Ottawa Hospital	Ottawa	Ontario

Sponsors (2)

Lead Sponsor	Collaborator
Ottawa Hospital Research Institute	Ottawa Regional Cancer Centre

Country where clinical trial is conducted

Canada, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Qualitative description of participants perception		after 6 month	No